138 related articles for article (PubMed ID: 7756638)
1. Involvement of the cysteine-rich domain of glycoprotein IIIa in the expression of the human platelet alloantigen, PlA1: evidence for heterogeneity in the humoral response.
Valentin N; Visentin GP; Newman PJ
Blood; 1995 Jun; 85(11):3028-33. PubMed ID: 7756638
[TBL] [Abstract][Full Text] [Related]
2. Localization of a PlA1 epitope to the amino terminal 66 residues of platelet glycoprotein IIIa.
Bowditch RD; Tani PH; Halloran CE; Frelinger AL; McMillan R; Ginsberg MH
Blood; 1992 Feb; 79(3):559-62. PubMed ID: 1370635
[TBL] [Abstract][Full Text] [Related]
3. A 13-mer peptide straddling the leucine33/proline33 polymorphism in glycoprotein IIIa does not define the PLA1 epitope.
Flug F; Espinola R; Liu LX; SinQuee C; DaRosso R; Nardi M; Karpatkin S
Blood; 1991 May; 77(9):1964-9. PubMed ID: 1708295
[TBL] [Abstract][Full Text] [Related]
4. An amino acid polymorphism within the RGD binding domain of platelet membrane glycoprotein IIIa is responsible for the formation of the Pena/Penb alloantigen system.
Wang R; Furihata K; McFarland JG; Friedman K; Aster RH; Newman PJ
J Clin Invest; 1992 Nov; 90(5):2038-43. PubMed ID: 1430225
[TBL] [Abstract][Full Text] [Related]
5. Development of a monoclonal antibody capable of differentiating platelet PLA1/PLA1, PLA1/PLA2 and PLA2/PLA2 genotypes.
Liu LX; Nardi M; Flug F; Karpatkin S
Br J Haematol; 1992 May; 81(1):113-7. PubMed ID: 1520609
[TBL] [Abstract][Full Text] [Related]
6. Competitive binding of a monoclonal antibody SZ-21 with anti-PLA1 antibodies and its potential for clinical application.
Xi X; Zhao Y; Jiang H; Wu Q; Li P; Ruan C
Nouv Rev Fr Hematol (1978); 1992; 34(3):239-42. PubMed ID: 1383923
[TBL] [Abstract][Full Text] [Related]
7. On the association of the platelet-specific alloantigen, Pena, with glycoprotein IIIa. Evidence for heterogeneity of glycoprotein IIIa.
Furihata K; Nugent DJ; Bissonette A; Aster RH; Kunicki TJ
J Clin Invest; 1987 Dec; 80(6):1624-30. PubMed ID: 2445781
[TBL] [Abstract][Full Text] [Related]
8. A functional platelet fibrinogen receptor with a deletion in the cysteine-rich repeat region of the beta(3) integrin: the Oe(a) alloantigen in neonatal alloimmune thrombocytopenia.
Santoso S; Kiefel V; Richter IG; Sachs UJ; Rahman A; Carl B; Kroll H
Blood; 2002 Feb; 99(4):1205-14. PubMed ID: 11830467
[TBL] [Abstract][Full Text] [Related]
9. The human platelet alloantigens, PlA1 and PlA2, are associated with a leucine33/proline33 amino acid polymorphism in membrane glycoprotein IIIa, and are distinguishable by DNA typing.
Newman PJ; Derbes RS; Aster RH
J Clin Invest; 1989 May; 83(5):1778-81. PubMed ID: 2565345
[TBL] [Abstract][Full Text] [Related]
10. Construction of a human platelet alloantigen-1a epitope(s) within murine glycoprotein IIIa: identification of residues critical to the conformation of the antibody binding site(s).
Barron-Casella EA; Nebbia G; Rogers OC; King KE; Kickler TS; Casella JF
Blood; 1999 May; 93(9):2959-67. PubMed ID: 10216091
[TBL] [Abstract][Full Text] [Related]
11. A point mutation leads to an unpaired cysteine residue and a molecular weight polymorphism of a functional platelet beta 3 integrin subunit. The Sra alloantigen system of GPIIIa.
Santoso S; Kalb R; Kroll H; Walka M; Kiefel V; Mueller-Eckhardt C; Newman PJ
J Biol Chem; 1994 Mar; 269(11):8439-44. PubMed ID: 8132570
[TBL] [Abstract][Full Text] [Related]
12. GPIIIa-related PLA1 antigens with different molecular weights: studies in platelets, endothelial cells, and megakaryocytes.
Dancis A; Ehmann C; Ferziger R; Grima K; Karpatkin S
Blood; 1988 Apr; 71(4):1056-61. PubMed ID: 3355887
[TBL] [Abstract][Full Text] [Related]
13. A monoclonal antibody (LK-4) which differentiates PLA1 from PLA2 platelet extracts but not intact platelets.
Liu LX; Nardi MA; Flug F; Karpatkin S
Thromb Res; 1992 May; 66(4):309-20. PubMed ID: 1384161
[TBL] [Abstract][Full Text] [Related]
14. Expression and purification of functional recombinant epitopes for the platelet antigens, PlA1 and PlA2.
Barron-Casella EA; Kickler TS; Rogers OC; Casella JF
Blood; 1994 Aug; 84(4):1157-63. PubMed ID: 7519475
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of binding of anti-PLA1 antibodies to platelets with monoclonal antibody LK-4. Evidence for multiple PLA1 receptor sites on platelet GPIIIa.
Liu LX; Nardi MA; Casella JF; Karpatkin S
Blood; 1996 Nov; 88(9):3601-7. PubMed ID: 8896429
[TBL] [Abstract][Full Text] [Related]
16. Neonatal alloimmune thrombocytopenia due to a new platelet-specific alloantibody.
McFarland JG; Blanchette V; Collins J; Newman PJ; Wang R; Aster RH
Blood; 1993 Jun; 81(12):3318-23. PubMed ID: 8507868
[TBL] [Abstract][Full Text] [Related]
17. Further characterization of the loop structure of platelet glycoprotein IIIa: partial mapping of functionally significant glycoprotein IIIa epitopes.
Kouns WC; Newman PJ; Puckett KJ; Miller AA; Wall CD; Fox CF; Seyer JM; Jennings LK
Blood; 1991 Dec; 78(12):3215-23. PubMed ID: 1720699
[TBL] [Abstract][Full Text] [Related]
18. Effect of single amino acid substitutions on the formation of the PlA and Bak alloantigenic epitopes.
Goldberger A; Kolodziej M; Poncz M; Bennett JS; Newman PJ
Blood; 1991 Aug; 78(3):681-7. PubMed ID: 1713513
[TBL] [Abstract][Full Text] [Related]
19. Assignment of disulphide bonds in human platelet GPIIIa. A disulphide pattern for the beta-subunits of the integrin family.
Calvete JJ; Henschen A; González-Rodríguez J
Biochem J; 1991 Feb; 274 ( Pt 1)(Pt 1):63-71. PubMed ID: 2001252
[TBL] [Abstract][Full Text] [Related]
20. Quantitative determination of platelet surface alloantigens using a monoclonal probe.
Janson M; McFarland J; Aster RH
Hum Immunol; 1986 Mar; 15(3):251-62. PubMed ID: 3754249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
